Supplementary Information
1H NMR Data of the Polymers Synthesized PMestOx
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 297 H), 3.46 (br, NCH2CH2N, 396 H), 3.14 (br, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (br, COCH2CH2CO, 396 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H)
PC3MestOx
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 267 H), 3.46 (br, NCH2CH2N, 356 H), 3.14 (br, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (br, COCH2CH2CH2CO, 356 H), 1.90 (br, COCH2CH2CH2CO, 178 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H)
PnPropOx
1H NMR (CDCl3, 300 MHz): δ 3.46 (br, NCH2CH2N, 380 H), 3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.27 (b, COCH2, 190 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 190 H), 0.95 (br, CH2CH3, 285 H)
P(EtOx-MestOx, 90:10)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 24 H), 3.46 (br, NCH2CH2N, 380 H), 3.14 (b,
CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 32 H), 2.27 (b, COCH2, 174 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 261 H)
P(EtOx-MestOx, 80:20)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 57 H), 3.46 (br, NCH2CH2N, 388 H), 3.14 (b,
CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 76 H), 2.27 (b, COCH2, 156 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 234 H)
P(EtOx-MestOx, 70:30)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 87 H), 3.46 (br, NCH2CH2N, 388 H), 3.14 (b,
CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 116 H), 2.27 (b, COCH2, 136 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 204 H)
P(EtOx-MestOx, 50:50)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 147 H), 3.46 (br, NCH2CH2N, 384 H), 3.14 (b,
CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 196 H), 2.27 (b, COCH2, 96 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 144 H)
P(EtOx-MestOx, 30:70)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 207 H), 3.46 (br, NCH2CH2N, 388 H), 3.14 (b,
CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 276 H), 2.27 (b, COCH2, 56 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 84 H)
P(EtOx-C3MestOx, 90:10)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 30 H), 3.46 (br, NCH2CH2N, 392 H), 3.14 (b,
CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 40 H), 2.27 (b, COCH2, 174 H), 1.90 (br, COCH2CH2CH2CO, 20 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 261 H)
P(EtOx-C3MestOx, 80:20)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 57 H), 3.46 (br, NCH2CH2N, 392 H), 3.14 (b,
96 H), 1.90 (br, COCHCHCHCO, 98 H), 1.78 (s, CHCHCH piperidine, 6 H), 1.12 (br, CHCH, 144 H)
P(EtOx-C3MestOx, 30:70)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 204 H), 3.46 (br, NCH2CH2N, 384 H), 3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 204 H), 2.27 (b, COCH2, 56 H), 1.90 (br, COCH2CH2CH2CO, 136 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.12 (br, CH2CH3, 84 H)
P(nPropOx-MestOx, 90:10)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 30 H), 3.46 (br, NCH2CH2N, 376 H), 3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 40 H), 2.27 (b, COCH2, 168 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 168 H), 0.95 (br, CH2CH3, 252 H)
P(nPropOx-MestOx, 80:20)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 57 H), 3.46 (br, NCH2CH2N, 396 H), 3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 76 H), 2.27 (b, COCH2, 160 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 160 H), 0.95 (br, CH2CH3, 240 H)
P(nPropOx-MestOx, 70:30)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 87 H), 3.46 (br, NCH2CH2N, 368 H), 3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 116 H), 2.27 (b, COCH2, 126 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 126 H), 0.95 (br, CH2CH3, 189 H)
P(nPropOx-MestOx, 50:50)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 150 H), 3.46 (br, NCH2CH2N, 380 H), 3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 200 H), 2.27 (b, COCH2, 90 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 90 H), 0.95 (br, CH2CH3, 135 H)
P(nPropOx-MestOx, 30:70)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 231 H), 3.46 (br, NCH2CH2N, 420 H), 3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CO, 308 H), 2.27 (b, COCH2, 56 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 56 H), 0.95 (br, CH2CH3, 118 H)
P(nPropOx-C3MestOx, 90:10)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 30 H), 3.46 (br, NCH2CH2N, 416 H), 3.14 (b,
CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 40 H), 2.27 (b, COCH2, 188 H), 1.90 (br, COCH2CH2CH2CO, 20 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 188 H), 0.95 (br, CH2CH3, 282 H)
P(nPropOx-C3MestOx, 80:20)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 57 H), 3.46 (br, NCH2CH2N, 368 H), 3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 76 H), 2.27 (b, COCH2, 146 H), 1.90 (br, COCH2CH2CH2CO, 38 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 146 H), 0.95 (br, CH2CH3, 292 H)
P(nPropOx-C3MestOx, 70:30)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 87 H), 3.46 (br, NCH2CH2N, 372 H), 3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 116 H), 2.27 (b, COCH2, 168 H), 1.90 (br, COCH2CH2CH2CO, 58 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 168 H), 0.95 (br, CH2CH3, 192 H)
P(nPropOx-C3MestOx, 50:50)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 147 H), 3.46 (br, NCH2CH2N, 376 H), 3.14 (b, CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 196 H), 2.27 (b, COCH2, 90 H), 1.90 (br, COCH2CH2CH2CO, 98 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 90 H), 0.95 (br, CH2CH3, 175 H)
P(nPropOx-C3MestOx, 30:70)
1H NMR (CDCl3, 300 MHz): δ 3.64 (br, COOCH3, 204 H), 3.46 (br, NCH2CH2N, 380 H), 3.14 (b,
CH2NCH2 piperidine, 4 H), 2.96 (s, NCH3, 3 H), 2.63 (b, COCH2CH2CH2CO, 272 H), 2.27 (b, COCH2, 54 H), 1.90 (br, COCH2CH2CH2CO, 136 H), 1.78 (s, CH2CH2CH2 piperidine, 6 H), 1.63 (b, COCH2CH2, 54 H), 0.95 (br, CH2CH3, 81 H)
Figure S1. Turbidity curves during heating and cooling of P(nPropOx) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S2. Turbidity curves during heating and cooling of P(EtOx-MestOx, 90:10) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S3. Turbidity curves during heating and cooling of P(EtOx-MestOx, 80:20) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S4. Turbidity curves during heating and cooling of P(EtOx-MestOx, 70:30) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S5. Turbidity curves during heating and cooling of P(EtOx-MestOx, 50:50) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S6. Turbidity curves during heating and cooling of P(EtOx-MestOx, 30:70) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S7. Turbidity curves during heating and cooling of P(EtOx-C3MestOx, 90:10) aqueous solutions (5 mg/mL) with aheating/cooling rate of 1 °C min−1.
Figure S8. Turbidity curves during heating and cooling of P(EtOx-C3MestOx, 80:20) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S9. Turbidity curves during heating and cooling of P(EtOx-C3MestOx, 70:30) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S10. Turbidity curves during heating and cooling of P(EtOx-C3MestOx, 50:50) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S11. Turbidity curves during heating and cooling of P(EtOx-C3MestOx, 30:70) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S12. Turbidity curves during heating and cooling of P(nPropOx-MestOx, 90:10) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S13. Turbidity curves during heating and cooling of P(nPropOx-MestOx, 80:20) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S14. Turbidity curves during heating and cooling of P(nPropOx-MestOx, 70:30) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S15. Turbidity curves during heating and cooling of P(nPropOx-MestOx, 50:50) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S16. Turbidity curves during heating and cooling of P(nPropOx-MestOx, 30:70) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S17. Turbidity curves during heating and cooling of P(nPropOx-C3MestOx, 90:10) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S18. Turbidity curves during heating and cooling of P(nPropOx-C3MestOx, 80:20) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S19. Turbidity curves during heating and cooling of P(nPropOx-C3MestOx, 70:30) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S20. Turbidity curves during heating and cooling of P(nPropOx-C3MestOx, 50:50) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S21. Turbidity curves during heating and cooling of P(nPropOx-C3MestOx, 30:70) aqueous solutions (5 mg/mL) with a heating/cooling rate of 1 °C min−1.
Figure S22. 1H NMR spectrum of P(EtOx-MestOx, 30:70) before TCP measurements in CDCl3.
The decrease of the methyl ester is determined by the integration of all side CH2 protons of the sidechains (peaks of CH2 next to methyl ester and carboxylic acid are overlapping, δ 2.17–2.90 ppm) and compared those with the overlapping peaks of the backbone and the methyl ester (δ 3.37–3.80 ppm).
Figure S24. DSC traces of second heating run (10 K min-1) of P(EtOx-MestOx).
Figure S25. DSC traces of second heating run (10 K min-1) of P(EtOx-C3MestOx).
Figure S27. DSC traces of second heating run (10 K min-1) of P(nPropOx-C3MestOx).
Figure S28. Thermogravimetric analysis of P(EtOx-MestOx) copolymers under nitrogen atmosphere at a heating rate of 10 ° C min−1.
Figure S29. Thermogravimetric analysis of P(nPropOx-MestOx) copolymers under nitrogen atmosphere at a heating rate of 10 ° C min−1.
Figure S30. Thermogravimetric analysis of P(nPropOx-C3MestOx) copolymers under nitrogen atmosphere at a heating rate of 10 ° C min−1.
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).